ELIMUSERTIB | ELIMUSERTIB : Inhibitor of ATR
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
ATR
  • IC50:7 nM
  • IC50:36 nM
  • IC50:9 nM
  • IC50:71 nM
  • IC50:160 nM
Inhibitor
up to 1 uM

Selectivity

In Vitro Selectivity Assessment
Potency Assay Off-Target:
BAY 1895344 was evaluated in an in-house kinase selectivity panel, as well as by KINOMEscan profilin ...
In Cell Selectivity Assessment
Potency Assay Off-Target:
BAY 1895344 showed good selectivity against mTOR (ratio of IC50 values: mTOR/ATR 61) in cellular mec ...

Potency
Cellular
In Vitro

ATR

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? Yes

DOI Reference: 10.1021/acs.jmedchem.0c00369

In Vivo Validations

Mouse
Dose:
Route of delivery: Intravenous, Oral
Plasma half life: 0.17 h (apparent)
Systemic clearance: 3.5 L/h/kg
Volume of Distribution at Steady-State: 8.8 L/Kg

DOI Reference: 10.1021/acs.jmedchem.0c00369

Dose: 4 mg/Kg
Route of delivery: Intravenous
Plasma half life: 90.9 min
Systemic clearance: 55.8 mL/min/Kg
Cmax: 2573 ng/mL
Tmax: 5 min
Area Under the Curve:: 58.2 ug/mL*min
Volume of Distribution at Steady-State: 7.31 L/Kg

DOI Reference: 10.1007/s00280-022-04436-0

Dose: 4 mg/Kg
Route of delivery: Oral
Plasma half life: 125 min
Systemic clearance: 432 mL/min/Kg
Cmax: 110.0 ng/mL
Tmax: 15 min
Area Under the Curve:: 8.37 ug/mL*min
Volume of Distribution at Steady-State: 77.7 L/Kg

DOI Reference: 10.1007/s00280-022-04436-0

Rat
Dose:
Route of delivery: Intravenous, Oral
Plasma half life: 1.3 h (apparent)
Systemic clearance: 1.2 L/h/kg
Bioavailability: 87%
Volume of Distribution at Steady-State: 1.7 L/Kg

DOI Reference: 10.1021/acs.jmedchem.0c00369

Dog
Dose:
Route of delivery: Intravenous, Oral
Plasma half life: 1.0 h (apparent)
Systemic clearance: 0.79 L/h/kg
Bioavailability: 51%
Volume of Distribution at Steady-State: 1.0 L/Kg

DOI Reference: 10.1021/acs.jmedchem.0c00369

Chemical Information

Molecular Formula C20H21N7O
SMILEs C[C@@H]1COCCN1c1cc(-c2ccnn2C)c2ccnc(-c3ccn[nH]3)c2n1
InChI InChI=1S/C20H21N7O/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-16/h3-8,11,13H,9-10,12H2,1-2H3,(H,22,25)/t13-/m1/s1
Molecular weight 375.18 Da
AlogP 0.0
HBond acceptors 8
HBond donors 1
Atoms 49

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


No SERP comments found for ELIMUSERTIB

Probe ELIMUSERTIB is in the process of SERP review.

Please continue to check back for new reviews and commentary.